SCHEMBL8217609

SCHEMBL8217609

CC(C)(c1cc(N)nc(-c2ccc(NC(=O)NC3CCC3)cc2)n1)S(=O)(=O)c1ccccc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
EPHX2 P34913 5/20 0.40
FPR2 P25090 3/20 0.40
FPR1 P21462 1/20 0.39
EPHX1 P07099 2/20 0.38
DGAT1 O75907 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.38
IGF1R P08069 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8219083 0.87 NAMPT (0.40) CA12CA1CA2CA9RAB9A
SCHEMBL11926888 0.85 KIF11 (0.43) PTGS2TRPV1IGF1R
SCHEMBL8214017 0.85 CYP3A4 (0.43) PTGS2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8215290 0.85 PIK3CD (0.46) RAB9AIGF1R
SCHEMBL8214559 0.84 EPHX2 (0.41) CYP3A4CYP2D6CYP2C9CYP2C19CA12
SCHEMBL8211453 0.84 CYP3A4 (0.47) CYP3A4CYP2D6CYP2C9CYP2C19CA12
SCHEMBL8218995 0.84 CYP3A4 (0.47) CYP3A4CYP2D6CYP2C9CYP2C19CA12
SCHEMBL8217047 0.84 EPHX1 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19CA12
SCHEMBL8219081 0.83 NAMPT (0.43) RAB9AIGF1R
SCHEMBL8214025 0.83 EPHX1 (0.47) PTGS2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008023159-A1 MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-02-28 WO disclosed